Want to create an interactive transcript for this episode?
Podcast: Grassroots Marketing
Episode: Psychedelic Science 2023: PhD DemeRx Inc CEO & Founder, Deborah Mash
Description: Deborah Mash is one of the world's foremost experts on the psychedelic drug ibogaine. She is the CEO and Founder of DemeRx Inc., a clinical-stage drug development company advancing ibogaine and its active metabolite noribogaine for the treatment of opioid use disorder. DemeRx has partnered with ATAI Life Sciences -- a global biotech platform with a special focus on psychedelic medicine -- to develop ibogaine for those suffering from opioid use disorder. Building on the extensive human data available around ibogaine. DemeRx and ATAI will submit Clinical Trial Applications for a Phase II study in opioid-dependent patients. T...